top of page
GO DEEP
Conforma Reduce
View Clinical Data and Publications
Conforma Reduce
is Absorbed through
Intact Skin
-
DCA physically disrupts the cell membrane of adipocytes causing cell death; fat is more sensitive to the cytolytic effects of DCA than relatively protein-rich tissues such as skin and muscle. (Dermatol Surg 2010;36:899-908)
-
KybellaTM (DCA injection; Allergan/Kythera Biopharmaceuticals) was approved as a first-in-class injectable drug for submental fat reduction in 2015.

-
The dose-limiting side effects of DCA injection are pain, swelling, and inflammation
Conforma Reduce
contains Molecular Nano-assembled DCA
Conforma-Reduce is a thermodynamically stable dispersion of DCA in the form of 2 nm particles (as observed by TEM (transmission electron microscopy).
Deoxycholic Acid
Conforma-Reduce
Conforma Reduce
Clinical Study
CONFORMA REDUCE cream significantly decreased the surface area and volume of the chin region when measured at 4 and 8 weeks, compared to placebo. PLUS: No adverse dermal effects were reported with CONFORMA REDUCE.
Double Chin Area Changes
Starting Point
4 weeks
8 weeks
(24% reduction)
Conforma Reduce cream was utilized in 42 women (mean age 47.8 y.o.) with daily topical administration. • At weeks 4 and 8, DSLR and Vectra XT measure the area (pixel) and volume of the double chin was assessed.
bottom of page